{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EU ORPHAN DRUG|Positive|Treatment of myelofibrosis" in comments (approximate match)
Showing 1 - 2 of 2 results
Status:
US Approved Rx
(2024)
Source:
NDA217779
(2024)
Source URL:
First approved in 2024
Source:
NDA217779
Source URL:
Class (Stereo):
CHEMICAL (MIXED)
Status:
Investigational
Source:
NCT04262141: Phase 2 Interventional Active, not recruiting Essential Thrombocythemia
(2020)
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
